Herbas VPB

Print
EN | LT
LT - BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
EN - BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/2878 (2013.01)
C07K 16/28 (2006.01)
G01N 33/574 (2006.01)
G01N 33/57407 (2013.01)
A61P 35/00 (2006.01)
G01N 33/6863 (2013.01)
C07K2317/31 (2013.01)
C07K2317/73 (2013.01)
G01N2333/70578 (2013.01)
G01N2800/22 (2013.01)
C07K2317/33 (2013.01)
C07K2317/92 (2013.01)
C07K 16/2809 (2013.01)
A61P 19/02 (2018.01)
A61P 29/00 (2018.01)
A61P 35/00 (2018.01)
A61P 37/02 (2018.01)
European patent
(11) Number of the document 3227333
(13) Kind of document T
(96) European patent application number 15804458.6
Date of filing the European patent application 2015-12-02
(97) Date of publication of the European application 2017-10-11
(45) Date of publication and mention of the grant of the patent 2023-08-16
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2015/078388
Date 2015-12-02
PCT application publication
(87) Number WO 2016/087531
Date 2016-06-09
Priority applications
(30) Number Date Country code
14196168 2014-12-03 EP
Inventors
(72)
VU, Minh Diem , CH
STREIN, Klaus , DE
HUNZIKER, Erich , CH
Grantee
(73) Bristol-Myers Squibb Company , Route 206 and Province Line Road, Princeton, NJ 08543-4000, US
Title
(54) BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
  BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES